Cardiovascular system heart and systemic circulation

High Altitude: Human Adaptation to Hypoxia

Volumn 9781461487722, Issue , 2014, Pages 103-139

  Baggish, Aaron L ^a   Wolfel, Eugene E ^b,c   Levine, Benjamin D ^c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d PRESBYTERIAN HOSPITAL OF DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929667824     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-8772-2_6     Document Type: Chapter

References (192)

1. Grollman A. Physiological variations of the cardic output of man. VII. The effects of high altitude on the cardiac output and its related functions: an account of experiments conducted on the summit of Pikes Peak, Colorado. Am J Physiol. 1930;93: 19-40.
2. Doyle JT, Wilson JS, Warren JV. The pulmonary vascular responses to short-term hypoxia in human subjects. Circulation. 1952;5(2):263-70.
3. Wescott RN, Fowler NO, Scott RC, Hauenstein VD, McGuire J. Anoxia and human pulmonary vascular resistance. J Clin Invest. 1951;19:957-70.
4. Vogel JA, Harris CW. Cardiopulmonary responses of resting man during early exposure to high altitude. J Appl Physiol. 1967;22(6):1124-8.
5. Stenberg J, Ekblom B, Messin R. Hemodynamic response to work at simulated altitude, 4,000 m. J Appl Physiol. 1966;21(5):1589-94.
6. Wagner PD, Gale GE, Moon RE, Torre-Bueno JR, Stolp BW, Saltzman HA. Pulmonary gas exchange in humans exercising at sea level and simulated altitude. J Appl Physiol. 1986;61(1):260-70.
7. Wagner JA, Miles DS, Horvath SM. Physiological adjustments of women to prolonged work during acute hypoxia. J Appl Physiol. 1980;49(3):367-73.
8. Levine BD, Zuckerman JH, deFilippi CR. Effect of high-altitude exposure in the elderly: the Tenth Mountain Division study. Circulation. 1997;96(4): 1224-32.
9. Richardson DW, Kontos HA, Raper AJ, Patterson Jr JL. Modification by beta-adrenergic blockade of the circulatory respones to acute hypoxia in man. J Clin Invest. 1967;46(1):77-85.
10. Koller EA, Drechsel S, Hess T, Macherel P, Boutellier U. Effects of atropine and propranolol on the respiratory, circulatory, and ECG responses to high altitude in man. Eur J Appl Physiol Occup Physiol. 1988;57(2):163-72.
11. Cunningham WL, Becker EJ, Kreuzer F. Catecholamines in plasma and urine at high altitude. J Appl Physiol. 1965;20(4):607-10.
12. Mazzeo RS, Wolfel EE, Butterfield GE, Reeves JT. Sympathetic response during 21 days at high altitude (4,300 m) as determined by urinary and arterial catecholamines. Metabolism. 1994;43(10):1226-32.
13. Mazzeo RS, Bender PR, Brooks GA, Butterfield GE, Groves BM, Sutton JR, et al. Arterial catecholamine responses during exercise with acute and chronic high-altitude exposure. Am J Physiol. 1991;261 (4 Pt 1):E419-24.
14. Leuenberger U, Gleeson K, Wroblewski K, Prophet S, Zelis R, Zwillich C, et al. Norepinephrine clearance is increased during acute hypoxemia in humans. Am J Physiol. 1991;261(5 Pt 2):H1659-64.
15. Perini R, Milesi S, Biancardi L, Veicsteinas A. Effects of high altitude acclimatization on heart rate variability in resting humans. Eur J Appl Physiol Occup Physiol. 1996;73(6):521-8.
16. Brown TE, Beightol LA, Koh J, Eckberg DL. Important influence of respiration on human R-R interval power spectra is largely ignored. J Appl Physiol. 1993;75(5):2310-7.
17. Shibata S, Zhang R, Hastings J, Fu Q, Okazaki K, Iwasaki K, et al. Cascade model of ventriculararterial coupling and arterial-cardiac baroreflex function for cardiovascular variability in humans. Am J Physiol Heart Circ Physiol. 2006;291(5): H2142-51.
18. Piepoli M, Sleight P, Leuzzi S, Valle F, Spadacini G, Passino C, et al. Origin of respiratory sinus arrhythmia in conscious humans. An important role for arterial carotid baroreceptors. Circulation. 1997; 95(7):1813-21.
19. Grassman E, Blomqvist CG. Absence of respiratory sinus arrhythmia: a manifestation of the sick sinus syndrome. Clin Cardiol. 1983;6(4):151-4.
20. Somers VK, Mark AL, Abboud FM. Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J Clin Invest. 1991;87(6):1953-7.
21. Saito M, Mano T, Iwase S, Koga K, Abe H, Yamazaki Y. Responses in muscle sympathetic activity to acute hypoxia in humans. J Appl Physiol. 1988;65(4): 1548-52.
22. Duplain H, Vollenweider L, Delabays A, Nicod P, Bartsch P, Scherrer U. Augmented sympathetic activation during short-term hypoxia and high-altitude exposure in subjects susceptible to high-altitude pulmonary edema. Circulation. 1999;99(13):1713-8.
23. Eckberg DL, Bastow III H, Scruby AE. Modulation of human sinus node function by systemic hypoxia. J Appl Physiol. 1982;52(3):570-7.
24. Kahler RL, Goldblatt A, Braunwald E. The effects of acute hypoxia on the systemic venous and arterial systems and on myocardial contractile force. J Clin Invest. 1962;41:1553-63.
25. Neubauer JA, Sunderram J. Oxygen-sensing neurons in the central nervous system. J Appl Physiol. 2004;96(1):367-74.
26. Mifflin SW, Felder RB. Synaptic mechanisms regulating cardiovascular afferent inputs to solitary tract nucleus. Am J Physiol. 1990;259(3 Pt 2):H653-61.
27. Dias AC, Vitela M, Colombari E, Mifflin SW. Nitric oxide modulation of glutamatergic, baroreflex, and cardiopulmonary transmission in the nucleus of the solitary tract. Am J Physiol Heart Circ Physiol. 2005;288(1):H256-62.
28. Reeves SR, Gozal D. Protein kinase C activity in the nucleus tractus solitarii is critically involved in the acute hypoxic ventilatory response, but is not required for intermittent hypoxia-induced phrenic long-term facilitation in adult rats. Exp Physiol. 2007;92(6):1057-66.
29. Reeves SR, Carter ES, Guo SZ, Gozal D. Calcium/ calmodulin-dependent kinase II mediates critical components of the hypoxic ventilatory response within the nucleus of the solitary tract in adult rats. Am J Physiol Regul Integr Comp Physiol. 2005;289(3):R871-6.
30. Hultgren HN. The systemic circulation. In: High altitude medicine. Stanford, CA: Hultgren Publications; 1997:33-63.
31. Reeves JT, Groves BM, Sutton JR, Wagner PD, Cymerman A, Malconian MK, et al. Operation Everest II: preservation of cardiac function at extreme altitude. J Appl Physiol. 1987;63(2):531-9.
32. Pool PE, Covell JW, Chidsey CA, Braunwald E. Myocardial high energy phosphate stores in acutely induced hypoxic heart failure. Circ Res. 1966;19: 221-9.
33. Kaufmann PA, Schirlo C, Pavlicek V, Berthold T, Burger C, von Schulthess GK, et al. Increased myocardial blood flow during acute exposure to simulated altitudes. J Nucl Cardiol. 2001;8(2):158-64.
34. Wyss CA, Koepfli P, Fretz G, Seebauer M, Schirlo C, Kaufmann PA. Influence of altitude exposure on coronary flow reserve. Circulation. 2003;108(10): 1202-7.
35. Chen CH, Liu YF, Lee SD, Huang CY, Lee WC, Tsai YL, et al. Altitude hypoxia increases glucose uptake in human heart. High Alt Med Biol. 2009;10(1):83-6.
36. Adrogue JV, Sharma S, Ngumbela K, Essop MF, Taegtmeyer H. Acclimatization to chronic hypobaric hypoxia is associated with a differential transcriptional profile between the right and left ventricle. Mol Cell Biochem. 2005;278(1-2):71-8.
37. Onishi K, Sekioka K, Ishisu R, Tanaka H, Nakamura M, Ueda Y, et al. Decrease in oxygen cost of contractility during hypocapnic alkalosis in canine hearts. Am J Physiol. 1996;270(6 Pt 2):H1905-13.
38. Heistad DD, Abboud FM, Dickinson W. Richards lecture: circulatory adjustments to hypoxia. Circulation. 1980;61(3):463-70.
39. Rowell LB, Saltin B, Kiens B, Christensen NJ. Is peak quadriceps blood flow in humans even higher during exercise with hypoxemia? Am J Physiol. 1986;251(5 Pt 2):H1038-44.
40. Hartley LH, Vogel JA, Landowne M. Central, femoral, and brachial circulation during exercise in hypoxia. J Appl Physiol. 1973;34(1):87-90.
41. Remensnyder JP, Mitchell JH, Sarnoff SJ. Functional sympatholysis during muscular activity. Observations on influence of carotid sinus on oxygen uptake. Circ Res. 1962;11:370-80.
42. Hansen J, Thomas GD, Harris SA, Parsons WJ, Victor RG. Differential sympathetic neural control of oxygenation in resting and exercising human skeletal muscle. J Clin Invest. 1996;98(2):584-96.
43. Thomas GD, Hansen J, Victor RG. ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Clin Invest. 1997;99(11):2602-9.
44. Thomas GD, Victor RG. Nitric oxide mediates contraction- induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Physiol. 1998;506(Pt 3):817-26.
45. Kojonazarov BK, Imanov BZ, Amatov TA, Mirrakhimov MM, Naeije R, Wilkins MR, et al. Noninvasive and invasive evaluation of pulmonary arterial pressure in highlanders. Eur Respir J. 2007;29(2):352-6.
46. Knight DR, Schaffartzik W, Poole DC, Hogan MC, Bebout DE, Wagner PD. Effects of hyperoxia on maximal leg O2 supply and utilization in men. J Appl Physiol. 1993;75(6):2586-94.
47. Hackett JG, Abboud FM, Mark AL, Schmid PG, Heistad DD. Coronary vascular responses to stimulation of chemoreceptors and baroreceptors: evidence for reflex activation of vagal cholinergic innervation. Circ Res. 1972;31(1):8-17.
48. Singel DJ, Stamler JS. Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annu Rev Physiol. 2005;67:99-145.
49. Gonzalez-Alonso J, Mortensen SP, Dawson EA, Secher NH, Damsgaard R. Erythrocytes and the regulation of human skeletal muscle blood flow and oxygen delivery: role of erythrocyte count and oxygenation state of haemoglobin. J Physiol. 2006;572(Pt 1):295-305.
50. Ellsworth ML, Forrester T, Ellis CG, Dietrich HH. The erythrocyte as a regulator of vascular tone. Am J Physiol. 1995;269(6 Pt 2):H2155-61.
51. Rosenmeier JB, Yegutkin GG, Gonzalez-Alonso J. Activation of ATP/UTP-selective receptors increases blood flow and blunts sympathetic vasoconstriction in human skeletal muscle. J Physiol. 2008;586 (Pt 20):4993-5002.
52. Dietrich HH, Ellsworth ML, Sprague RS, Dacey Jr RG. Red blood cell regulation of microvascular tone through adenosine triphosphate. Am J Physiol Heart Circ Physiol. 2000;278(4):H1294-8.
53. Abraham EH, Sterling KM, Kim RJ, Salikhova AY, Huffman HB, Crockett MA, et al. Erythrocyte membrane ATP binding cassette (ABC) proteins: MRP1 and CFTR as well as CD39 (ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosis. Blood Cells Mol Dis. 2001;27(1):165-80.
54. Sprague RS, Ellsworth ML, Stephenson AH, Kleinhenz ME, Lonigro AJ. Deformation-induced ATP release from red blood cells requires CFTR activity. Am J Physiol. 1998;275(5 Pt 2):H1726-32.
55. Sprague RS, Bowles EA, Hanson MS, DuFaux EA, Sridharan M, Adderley S, et al. Prostacyclin analogs stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes. Microcirculation. 2008;15(5):461-71.
56. Walsh MP, Marshall JM. The early effects of chronic hypoxia on the cardiovascular system in the rat: role of nitric oxide. J Physiol. 2006;575(Pt 1):263-75.
57. Ray CJ, Marshall JM. Measurement of nitric oxide release evoked by systemic hypoxia and adenosine from rat skeletal muscle in vivo. J Physiol. 2005;568(Pt 3):967-78.
58. Pyner S, Coney A, Marshall JM. The role of free radicals in the muscle vasodilatation of systemic hypoxia in the rat. Exp Physiol. 2003;88(6):733-40.
59. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med. 2003;9(12):1498-505.
60. Maher AR, Milsom AB, Gunaruwan P, Abozguia K, Ahmed I, Weaver RA, et al. Hypoxic modulation of exogenous nitrite-induced vasodilation in humans. Circulation. 2008;117(5):670-7.
61. Liu X, Srinivasan P, Collard E, Grajdeanu P, Lok K, Boyle SE, et al. Oxygen regulates the effective diffusion distance of nitric oxide in the aortic wall. Free Radic Biol Med. 2010;48(4):554-9.
62. Dalsgaard T, Simonsen U, Fago A. Nitrite-dependent vasodilation is facilitated by hypoxia and is independent of known NO-generating nitrite reductase activities. Am J Physiol. 2007;292(6):H3072-8.
63. Vanhatalo A, Fulford J, Bailey SJ, Blackwell JR, Winyard PG, Jones AM. Dietary nitrate reduces muscle metabolic perturbation and improves exercise tolerance in hypoxia. J Physiol. 2012;589 (Pt 22):5517-28.
64. Diesen DL, Hess DT, Stamler JS. Hypoxic vasodilation by red blood cells: evidence for an s-nitrosothiolbased signal. Circ Res. 2008;103(5):545-53.
65. Isbell TS, Sun CW, Wu LC, Teng X, Vitturi DA, Branch BG, et al. SNO-hemoglobin is not essential for red blood cell-dependent hypoxic vasodilation. Nat Med. 2008;14(7):773-7.
66. Coney AM, Marshall JM. Contribution of alpha2- adrenoceptors and Y1 neuropeptide Y receptors to the blunting of sympathetic vasoconstriction induced by systemic hypoxia in the rat. J Physiol. 2007;582(Pt 3):1349-59.
67. Hultgren HN. Circulatory responses to acute hypoxia in normal subjects at sea level. In: High altitude medicine. Stanford, CA: Hultgren Publications; 1997. p. 34
68. Wolfel EE, Selland MA, Mazzeo RS, Reeves JT. Systemic hypertension at 4,300 m is related to sympathoadrenal activity. J Appl Physiol. 1994; 76(4):1643-50.
69. Nielsen AM, Bisgard GE, Vidruk EH. Carotid chemoreceptor activity during acute and sustained hypoxia in goats. J Appl Physiol. 1988;65(4):1796-802.
70. Klausen K. Cardiac output in man in rest and work during and after acclimatization to 3,800 m. J Appl Physiol. 1966;21(2):609-16.
71. Karliner JS, Sarnquist FF, Graber DJ, Peters Jr RM, West JB. The electrocardiogram at extreme altitude: experience on Mt. Everest. Am Heart J. 1985;109(3 Pt 1):505-13.
72. Houston CS, Riley RL. Respiratory and circulatory changes during acclimatization to high altitude. Am J Physiol. 1947;140:565-88.
73. Fowles RE, Hultgren HN. Left ventricular function at high altitude examined by systolic time intervals and M-mode echocardiography. Am J Cardiol. 1983;52(7):862-6.
74. Alexander JK, Hartley LH, Modelski M, Grover RF. Reduction of stroke volume during exercise in man following ascent to 3,100 m altitude. J Appl Physiol. 1967;23(6):849-58.
75. Wolfel EE, Groves BM, Brooks GA, Butterfield GE, Mazzeo RS, Moore LG, et al. Oxygen transport during steady-state submaximal exercise in chronic hypoxia. J Appl Physiol. 1991;70(3):1129-36.
76. Vogel JA, Hansen JE, Harris CW. Cardiovascular responses in man during exhaustive work at sea level and high altitude. J Appl Physiol. 1967;23(4): 531-9.
77. Dempsey JA, Thomson JM, Forster HV, Cerny FC, Chosy LW. HbO2 dissociation in man during prolonged work in chronic hypoxia. J Appl Physiol. 1975;38(6):1022-9.
78. Reeves JT, Grover RF, Cohn JE. Regulation of ventilation during exercise at 10,200 ft in athletes born at low altitude. J Appl Physiol. 1967;22(3):546-54.
79. Wolfel EE, Selland MA, Cymerman A, Brooks GA, Butterfield GE, Mazzeo RS, et al. O2 extraction maintains O2 uptake during submaximal exercise with beta-adrenergic blockade at 4,300 m. J Appl Physiol. 1998;85(3):1092-102.
80. Moore LG, Cymerman A, Huang SY, McCullough RE, McCullough RG, Rock PB, et al. Propranolol blocks metabolic rate increase but not ventilatory acclimatization to 4300 m. Respir Physiol. 1987;70(2):195-204.
81. Savard GK, Areskog NH, Saltin B. Cardiovascular response to exercise in humans following acclimatization to extreme altitude. Acta Physiol Scand. 1995;154(4):499-509.
82. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307(4):205-11.
83. Voelkel NF, Hegstrand L, Reeves JT, McMurty IF, Molinoff PB. Effects of hypoxia on density of betaadrenergic receptors. J Appl Physiol. 1981;50(2):363-6.
84. Kacimi R, Richalet JP, Corsin A, Abousahl I, Crozatier B. Hypoxia-induced downregulation of beta-adrenergic receptors in rat heart. J Appl Physiol. 1992;73(4):1377-82.
85. Richalet JP, Larmignat P, Rathat C, Keromes A, Baud P, Lhoste F. Decreased cardiac response to isoproterenol infusion in acute and chronic hypoxia. J Appl Physiol. 1988;65(5):1957-61.
86. Antezana AM, Kacimi R, Le Trong JL, Marchal M, Abousahl I, Dubray C, et al. Adrenergic status of humans during prolonged exposure to the altitude of 6,542 m. J Appl Physiol. 1994;76(3):1055-9.
87. Boushel R, Calbet JA, Radegran G, Sondergaard H, Wagner PD, Saltin B. Parasympathetic neural activity accounts for the lowering of exercise heart rate at high altitude. Circulation. 2001;104(15):1785-91.
88. Myhre LG, Dill DB, Hall FG, Brown DK. Blood volume changes during three-week residence at high altitude. Clin Chem. 1970;16(1):7-14.
89. Jain SC, Bardhan J, Swamy YV, Krishna B, Nayar HS. Body fluid compartments in humans during acute high-altitude exposure. Aviat Space Environ Med. 1980;51(3):234-6.
90. Robach P, Dechaux M, Jarrot S, Vaysse J, Schneider JC, Mason NP, et al. Operation Everest III: role of plasma volume expansion on VO(2)(max) during prolonged high-altitude exposure. J Appl Physiol. 2000;89(1):29-37.
91. Kubo SH, Clark M, Laragh JH, Borer JS, Cody RJ. Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics. Am J Cardiol. 1987;60(16):1322-8.
92. Thompson CA, Tatro DL, Ludwig DA, Convertino VA. Baroreflex responses to acute changes in blood volume in humans. Am J Physiol. 1990;259(4 Pt 2):R792-8.
93. Hansen J, Sander M. Sympathetic neural overactivity in healthy humans after prolonged exposure to hypobaric hypoxia. J Physiol. 2003;546(Pt 3):921-9.
94. Hoon RS, Balasubramanian V, Mathew OP, Tiwari SC, Sharma SC, Chadha KS. Effect of high-altitude exposure for 10 days on stroke volume and cardiac output. J Appl Physiol. 1977;42(5):722-7.
95. Groves BM, Reeves JT, Sutton JR, Wagner PD, Cymerman A, Malconian MK, et al. Operation Everest II: elevated high-altitude pulmonary resistance unresponsive to oxygen. J Appl Physiol. 1987;63(2):521-30.
96. Sutton JR, Reeves JT, Wagner PD, Groves BM, Cymerman A, Malconian MK, et al. Operation Everest II: oxygen transport during exercise at extreme simulated altitude. J Appl Physiol. 1988;64(4):1309-21.
97. Balasubramanian V, Behl A, Das GS, Wadhwa AK, Mathew OP, Hoon RS. Effect of digoxin and diuretics on high altitude left ventricular dysfunction. Circulation. 1978;57(6):1180-5.
98. Hartley LH, Alexander JK, Modelski M, Grover RF. Subnormal cardiac output at rest and during exercise in residents at 3,100 m altitude. J Appl Physiol. 1967;23(6):839-48.
99. Buch J, Egeblad H, Hansen PB, Kjaergard H, Waldorff S, Steiness E. Correlation between changes in systolic time intervals and left ventricular enddiastolic diameter after preload reduction. Noninvasive monitoring of pharmacological intervention. Br Heart J. 1980;44(6):668-71.
100. Suarez J, Alexander JK, Houston CS. Enhanced left ventricular systolic performance at high altitude during Operation Everest II. Am J Cardiol. 1987;60(1):137-42.
101. Webster KA, Bishopric NH. Molecular regulation of cardiac myocyte adaptations to chronic hypoxia. J Mol Cell Cardiol. 1992;24(7):741-51.
102. Mazer CD, Stanley WC, Hickey RF, Neese RA, Cason BA, Demas KA, et al. Myocardial metabolism during hypoxia: maintained lactate oxidation during increased glycolysis. Metabolism. 1990;39(9):913-8.
103. Arbab-Zadeh A, Levine BD, Trost JC, Lange RA, Keeley EC, Hillis LD, et al. The effect of acute hypoxemia on coronary arterial dimensions in patients with coronary artery disease. Cardiology. 2009;113(2):149-54.
104. Bunn HF, Poyton RO. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev. 1996;76(3):839-85.
105. Rassaf T, Flogel U, Drexhage C, Hendgen-Cotta U, Kelm M, Schrader J. Nitrite reductase function of deoxymyoglobin: oxygen sensor and regulator of cardiac energetics and function. Circ Res. 2007;100(12):1749-54.
106. Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, et al. An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA. 1996;93(23):12969-73.
107. Tan T, Marin-Garcia J, Damle S, Weiss HR. Hypoxia-inducible factor-1 improves inotropic responses of cardiac myocytes in ageing heart without affecting mitochondrial activity. Exp Physiol. 2010;95(6):712-22.
108. Kacimi R, Long CS, Karliner JS. Chronic hypoxia modulates the interleukin-1beta-stimulated inducible nitric oxide synthase pathway in cardiac myocytes. Circulation. 1997;96(6):1937-43.
109. Lau S, Patnaik N, Sayen MR, Mestril R. Simultaneous overexpression of two stress proteins in rat cardiomyocytes and myogenic cells confers protection against ischemia-induced injury. Circulation. 1997;96(7):2287-94.
110. Zimmerman LH, Levine RA, Farber HW. Hypoxia induces a specific set of stress proteins in cultured endothelial cells. J Clin Invest. 1991;87(3):908-14.
111. Zaobornyj T, Valdez LB, Iglesias DE, Gasco M, Gonzales GF, Boveris A. Mitochondrial nitric oxide metabolism during rat heart adaptation to high altitude: effect of sildenafil, L-NAME, and L-arginine treatments. Am J Physiol. 2009;296(6):H1741-7.
112. Hirata K, Ban T, Jinnouchi Y, Kubo S. Echocardiographic assessment of left ventricular function and wall motion at high altitude in normal subjects. Am J Cardiol. 1991;68(17):1692-7.
113. Cargill RI, Kiely DG, Lipworth BJ. Adverse effects of hypoxaemia on diastolic filling in humans. Clin Sci (Lond). 1995;89(2):165-9.
114. Allemann Y, Rotter M, Hutter D, Lipp E, Sartori C, Scherrer U, et al. Impact of acute hypoxic pulmonary hypertension on LV diastolic function in healthy mountaineers at high altitude. Am J Physiol Heart Circ Physiol. 2004;286(3):H856-62.
115. Huez S, Retailleau K, Unger P, Pavelescu A, Vachiery JL, Derumeaux G, et al. Right and left ventricular adaptation to hypoxia: a tissue Doppler imaging study. Am J Physiol Heart Circ Physiol. 2005;289(4):H1391-8.
116. Prasad A, Popovic ZB, Arbab-Zadeh A, Fu Q, Palmer D, Dijk E, et al. The effects of aging and physical activity on Doppler measures of diastolic function. Am J Cardiol. 2007;99(12):1629-36.
117. Jung RC, Dill DB, Horton R, Horvath SM. Effects of age on plasma aldosterone levels and hemoconcentration at altitude. J Appl Physiol. 1971;31(4): 593-7.
118. Surks MI, Chinn KS, Matoush LR. Alterations in body composition in man after acute exposure to high altitude. J Appl Physiol. 1966;21(6):1741-6.
119. Grover RF, Reeves JT, Maher JT, McCullough RE, Cruz JC, Denniston JC, et al. Maintained stroke volume but impaired arterial oxygenation in man at high altitude with supplemental CO2. Circ Res. 1976;38(5):391-6.
120. Grover RF, Selland MA, McCullough RG, Dahms TE, Wolfel EE, Butterfield GE, et al. Beta-adrenergic blockade does not prevent polycythemia or decrease in plasma volume in men at 4300 m altitude. Eur J Appl Physiol Occup Physiol. 1998;77(3):264-70.
121. Ross Jr J, Linhart JW, Brauwald E. Effects of changing heart rate in man by electrical stimulation of the right atrium. Studies at rest, during exercise, and with isoproterenol. Circulation. 1965;32(4):549-58.
122. Naeije R. Physiological adaptation of the cardiovascular system to high altitude. Prog Cardiovas Dis. 2010;52(6):456-66.
123. Malconian M, Rock P, Hultgren H, Donner H, Cymerman A, Groves B, et al. The electrocardiogram at rest and exercise during a simulated ascent of Mt. Everest (Operation Everest II). Am J Cardiol. 1990;65(22):1475-80.
124. Das BK, Tewari SC, Parashar SK, Akhtar M, Grover DN, Ohri VC, et al. Electrocardiographic changes at high attitude. Indian Heart J. 1983;35(1):30-3.
125. Abel FL, Waldhausen JA. Effects of alterations in pulmonary vascular resistance on right ventricular function. J Thorac Cardiovasc Surg. 1967;54(6): 886-94.
126. Davila-Roman VG, Guest TM, Tuteur PG, Rowe WJ, Ladenson JH, Jaffe AS. Transient right but not left ventricular dysfunction after strenuous exercise at high altitude. J Am Coll Cardiol. 1997;30(2): 468-73.
127. Atherton JJ, Moore TD, Lele SS, Thomson HL, Galbraith AJ, Belenkie I, et al. Diastolic ventricular interaction in chronic heart failure. Lancet. 1997;349(9067):1720-4.
128. Bernheim AM, Kiencke S, Fischler M, Dorschner L, Debrunner J, Mairbaurl H, et al. Acute changes in pulmonary artery pressures due to exercise and exposure to high altitude do not cause left ventricular diastolic dysfunction. Chest. 2007;132(2):380-7.
129. Calbet JA, Radegran G, Boushel R, Sondergaard H, Saltin B, Wagner PD. Effect of blood haemoglobin concentration on V(O2, max) and cardiovascular function in lowlanders acclimatised to 5260 m. J Physiol. 2002;545(Pt 2):715-28.
130. Bender PR, Groves BM, McCullough RE, McCullough RG, Huang SY, Hamilton AJ, et al. Oxygen transport to exercising leg in chronic hypoxia. J Appl Physiol. 1988;65(6):2592-7.
131. Weil JV, Byrne-Quinn E, Battock DJ, Grover RF, Chidsey CA. Forearm circulation in man at high altitude. Clin Sci. 1971;40(3):235-46.
132. Cruz JC, Grover RF, Reeves JT, Maher JT, Cymerman A, Denniston JC. Sustained venoconstriction in man supplemented with CO2 at high altitude. J Appl Physiol. 1976;40(1):96-100.
133. Cerretelli P, Marconi C, Deriaz O, Giezendanner D. After effects of chronic hypoxia on cardiac output and muscle blood flow at rest and exercise. Eur J Appl Physiol Occup Physiol. 1984;53(2):92-6.
134. Hellems HK, Ord JW, Talmers FN, Christensen RC. Effects of hypoxia on coronary blood flow and myocardial metabolism in normal human subjects. Circulation. 1963;16:893-8.
135. Moret P, Covarrubias E, Coudert J, Duchosal F. Cardiocirculatory adaptation to chronic hypoxia: comparative study of coronary flow, myocardial oxygen consumption and efficiency between sea level and high altitude residents. Acta Cardiol. 1972;27(2):283-305.
136. Grover RF, Lufschanowski R, Alexander JK. Alterations in the coronary circulation of man following ascent to 3,100 m altitude. J Appl Physiol. 1976;41(6):832-8.
137. Klausen K. Man's acclimatization to altitude during the first week at 3.800 M. Schweiz Z Sportmed. 1966;14(1):246-53.
138. Sharma SC, Balasubramanian V, Mathew OP, Hoon RS. Serial studies of heart rate, blood pressure and urinary catecholamine excretion on acute induction to high altitude (3658m). Indian J Chest Dis Allied Sci. 1977;19(1):16-20.
139. Vogel JA, Hartley LH, Cruz JC. Cardiac output during exercise in altitude natives at sea level and high altitude. J Appl Physiol. 1974;36(2):173-6.
140. Zamudio S, Douglas M, Mazzeo RS, Wolfel EE, Young DA, Rock PB, et al. Women at altitude: forearm hemodynamics during acclimatization to 4,300 m with alpha(1)-adrenergic blockade. Am J Physiol Heart Circ Physiol. 2001;281(6):H2636-44.
141. Mazzeo RS, Carroll JD, Butterfield GE, Braun B, Rock PB, Wolfel EE, et al. Catecholamine responses to alpha-adrenergic blockade during exercise in women acutely exposed to altitude. J Appl Physiol. 2001;90(1):121-6.
142. Bilo G, Caldara G, Styczkiewicz K, Revera M, Lombardi C, Giglio A, et al. Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude. J Hypertens. 2011;29(2):380-7.
143. Pugh LG, Gill MB, Lahiri S, Milledge JS, Ward MP, West JB. Muscular exercise at great altitudes. J Appl Physiol. 1964;19:431-40.
144. Sharma SC, Hoon RS, Balasubramanian V, Chadha KS. Urinary catecholamine excretion in temporary residents of high altitude. J Appl Physiol. 1978;44(5):725-7.
145. Marticorena E, Ruiz L, Severino J, Galvez J, Penaloza D. Systemic blood pressure in white men born at sea level: changes after long residence at high altitudes. Am J Cardiol. 1969;23(3):364-8.
146. Lewis SF, Taylor WF, Graham RM, Pettinger WA, Schutte JE, Blomqvist CG. Cardiovascular responses to exercise as functions of absolute and relative work load. J Appl Physiol. 1983;54(5):1314-23.
147. Vogel JA, Hartley LH, Cruz JC, Hogan RP. Cardiac output during exercise in sea-level residents at sea level and high altitude. J Appl Physiol. 1974;36(2):169-72.
148. Ferretti G, Boutellier U, Pendergast DR, Moia C, Minetti AE, Howald H, et al. Oxygen transport system before and after exposure to chronic hypoxia. Int J Sports Med. 1990;11 Suppl 1:S15-20.
149. Steinacker JM, Liu Y, Boning D, Halder A, Maassen N, Thomas A, et al. Lung diffusion capacity, oxygen uptake, cardiac output and oxygen transport during exercise before and after an himalayan expedition. Eur J Appl Physiol Occup Physiol. 1996;74(1-2): 187-93.
150. Moore LG, Cymerman A, Huang SY, McCullough RE, McCullough RG, Rock PB, et al. Propranolol does not impair exercise oxygen uptake in normal men at high altitude. J Appl Physiol. 1986; 61(5):1935-41.
151. Grover RF, Weil JV, Reeves JT. Cardiovascular adaptation to exercise at high altitude. Exerc Sport Sci Rev. 1986;14:269-302.
152. Casey DP, Joyner MJ. Local control of skeletal muscle blood flow during exercise: influence of available oxygen. J Appl Physiol. 2011;111(6):1527-38.
153. Cerretelli P. Limiting factors to oxygen transport on Mount Everest. J Appl Physiol. 1976;40(5):658-67.
154. West JB, Boyer SJ, Graber DJ, Hackett PH, Maret KH, Milledge JS, et al. Maximal exercise at extreme altitudes on Mount Everest. J Appl Physiol. 1983;55(3):688-98.
155. Wagner PD. Why does the maximal exercise cardiac output fall during altitude residence at extreme altitudes and is it important? Proceedings of the 11th International Hypoxia Symposium, Jasper, Alberta; 1999.
156. Saltin B, Grover RF, Blomqvist CG, Hartley LH, JOhnson RL. Maximal oxygen uptake and cardiac output after 2 weeks at 4,300 m. J Appl Physiol. 1968;25:400-9.
157. Hartley LH, Vogel JA, Cruz JC. Reduction of maximal exercise heart rate at altitude and its reversal with atropine. J Appl Physiol. 1974;36(3):362-5.
158. Zhuang J, Droma T, Sutton JR, McCullough RE, McCullough RG, Groves BM, et al. Autonomic regulation of heart rate response to exercise in Tibetan and Han residents of Lhasa (3,658 m). J Appl Physiol. 1993;75(5):1968-73.
159. Garcia JA, McMinn SB, Zuckerman JH, Fixler DE, Levine BD. The role of the right ventricle during hypobaric hypoxic exercise: insights from patients after the Fontan operation. Med Sci Sports Exerc. 1999;31(2):269-76.
160. Young AJ, Sawka MN, Muza SR, Boushel R, Lyons T, Rock PB, et al. Effects of erythrocyte infusion on VO2max at high altitude. J Appl Physiol. 1996;81(1):252-9.
161. Robach P, Calbet JA, Thomsen JJ, Boushel R, Mollard P, Rasmussen P, et al. The ergogenic effect of recombinant human erythropoietin on VO2max depends on the severity of arterial hypoxemia. PLoS One. 2008;3(8):e2996.
162. Sime F, Penaloza D, Ruiz L. Bradycardia, increased cardiac output, and reversal of pulmonary hypertension in altitude natives living at sea level. Br Heart J. 1971;33(5):647-57.
163. Passino C, Bernardi L, Spadacini G, Calciati A, Robergs R, Anand I, et al. Autonomic regulation of heart rate and peripheral circulation: comparison of high altitude and sea level residents. Clin Sci (Lond). 1996;91(Suppl):81-3.
164. Hochachka PW, Clark CM, Holden JE, Stanley C, Ugurbil K, Menon RS. 31P magnetic resonance spectroscopy of the Sherpa heart: a phosphocreatine/ adenosine triphosphate signature of metabolic defense against hypobaric hypoxia. Proc Natl Acad Sci USA. 1996;93(3):1215-20.
165. Holden JE, Stone CK, Clark CM, Brown WD, Nickles RJ, Stanley C, et al. Enhanced cardiac metabolism of plasma glucose in high-altitude natives: adaptation against chronic hypoxia. J Appl Physiol. 1995;79(1):222-8.
166. Moret P. Cotronary blood flow and myocardial metabolism in man at hihg altitude. In: Porter R, Knight J, editors. High altitude physiology: cardiac and respiratory aspects. Edinburgh: Churchill Livingston; 1971. p. 131-48.
167. Arias-Stella J, Topilsky M. Anatomy of the coronary circulation at high al;titude. In: Porter R, Knight J, editors. High altitude physiology: cardiac and respiratory aspects. Edinburgh: Churchill Livingstone; 1971. p. 149-57.
168. Fuster V, Frye RL, Kennedy MA, Connolly DC, Mankin HT. The role of collateral circulation in the various coronary syndromes. Circulation. 1979;59(6):1137-44.
169. Mortimer Jr EA, Monson RR, MacMahon B. Reduction in mortality from coronary heart disease in men residing at high altitude. N Engl J Med. 1977;296(11):581-5.
170. Beall CM, Brittenham GM, Strohl KP, Blangero J, Williams-Blangero S, Goldstein MC, et al. Hemoglobin concentration of high-altitude Tibetans and Bolivian Aymara. Am J Phys Anthropol. 1998;106(3):385-400.
171. Beall CM, Strohl KP, Blangero J, Williams-Blangero S, Almasy LA, Decker MJ, et al. Ventilation and hypoxic ventilatory response of Tibetan and Aymara high altitude natives. Am J Phys Anthropol. 1997;104(4):427-47.
172. Winslow RM, Chapman KW, Gibson CC, Samaja M, Monge CC, Goldwasser E, et al. Different hematologic responses to hypoxia in Sherpas and Quechua Indians. J Appl Physiol. 1989;66(4):1561-9.
173. Hoit BD, Dalton ND, Erzurum SC, Laskowski D, Strohl KP, Beall CM. Nitric oxide and cardiopulmonary hemodynamics in Tibetan highlanders. J Appl Physiol. 2005;99(5):1796-801.
174. Antezana AM, Antezana G, Aparicio O, Noriega I, Velarde FL, Richalet JP. Pulmonary hypertension in high-altitude chronic hypoxia: response to nifedipine. Eur Respir J. 1998;12(5):1181-5.
175. Beall CM. Two routes to functional adaptation: Tibetan and Andean high-altitude natives. Proc Natl Acad Sci USA. 2007;104 Suppl 1:8655-60.
176. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315(17): 1046-51.
177. Vita JA, Treasure CB, Yeung AC, Vekshtein VI, Fantasia GM, Fish RD, et al. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation. 1992;85(4):1390-7.
178. Fuster V, Lewis A. Conner memorial lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 1994;90(4):2126-46.
179. Bartsch P, Waber U, Haeberli A, Maggiorini M, Kriemler S, Oelz O, et al. Enhanced fibrin formation in high-altitude pulmonary edema. J Appl Physiol. 1987;63(2):752-7.
180. Schobersberger W, Schmid P, Lechleitner M, von Duvillard SP, Hortnagl H, Gunga HC, et al. Austrian Moderate Altitude Study 2000 (AMAS 2000). The effects of moderate altitude (1,700 m) on cardiovascular and metabolic variables in patients with metabolic syndrome. Eur J Appl Physiol. 2003;88(6):506-14.
181. Burke AP, Farb A, Malcom GT, Liang Y, Smialek JE, Virmani R. Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA. 1999;281(10):921-6.
182. Faeh D, Gutzwiller F, Bopp M. Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation. 2009;120(6):495-501.
183. Morgan BJ, Alexander JK, Nicoli SA, Brammell HL. The patient with coronary disease at altitude: observations during acute exposure to 3,100 m. J Wilderness Med. 1990;1:147-53.
184. Gibelli G, Fantoni C, Anza C, Cattaneo P, Rossi A, Montenero AS, et al. Arrhythmic risk evaluation during exercise at high altitude in healthy subjects: role of microvolt T-wave alternans. Pacing Clin Electrophysiol. 2008;31(10):1277-83.
185. Woods DR, Allen S, Betts TR, Gardiner D, Montgomery H, Morgan JM, et al. High altitude arrhythmias. Cardiology. 2008;111(4):239-46.
186. Erdmann J, Sun KT, Masar P, Niederhauser H. Effects of exposure to altitude on men with coronary artery disease and impaired left ventricular function. Am J Cardiol. 1998;81(3):266-70.
187. Van Patot MC, Hill AE, Dingmann C, Gaul L, Fralick K, Christians U, et al. Risk of impaired coagulation in warfarin patients ascending to altitude (>2400 m). High Alt Med Biol. 2006;7(1):39-46.
188. Alexander JK, Abinader EG, Sharif DS, Morgan BJ, Brammell HL. Left ventricular function in coronary heart disease at high altitude. Circulation. 1988;78(Suppl II):2-6.
189. Agostoni P, Cattadori G, Guazzi M, Bussotti M, Conca C, Lomanto M, et al. Effects of simulated altitude-induced hypoxia on exercise capacity in patients with chronic heart failure. Am J Med. 2000;109(6):450-5.
190. Burtscher M, Philadelphy M, Likar R. Sudden cardiac death during mountain hiking and downhill skiing. N Engl J Med. 1993;329(23):1738-9.
191. Ponchia A, Biasin R, Tempesta T, Thiene M, Volta SD. Cardiovascular risk during physical activity in the mountains. J Cardiovasc Med (Hagerstown). 2006;7(2):129-35.
192. Burtscher M, Pachinger O, Schocke MF, Ulmer H. Risk factor profile for sudden cardiac death during mountain hiking. Int J Sports Med. 2007;28(7): 621-4.